Balanced news tone
News Sentiment
MRK sentiment intelligence
Merck & Co., Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
83/100 classification confidence.
directly relevant articles
high-authority source matches
+5.5% over one week, +16.8% over four weeks, trend active, and near fair-value range.
Branded Pharmaceuticals Stocks Q1 Results: Benchmarking Merck (NYSE:MRK)
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Branded Pharmaceuticals Stocks Q1 Results: Benchmarking Merck (NYSE:MRK)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Jul 2026 03:35
- Source
- TradingView
Merck (MRK) Declines More Than Market: Some Information for Investors
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 20 Jul 2026 21:50
- Source
- Market source
Merck & Co., Inc. (MRK) Stock Analysis: Navigating a 5.13% Upside Potential Amid Robust Growth
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 20 Jul 2026 09:07
- Source
- DirectorsTalk Interviews
Merck Stock And 2 Cash Flow Picks Trading Below Fair Value
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 19 Jul 2026 22:38
- Source
- simplywall.st
Merck (MRK) Stock Looks Cheap On Cash Flow While Earnings Look Fair
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 19 Jul 2026 13:22
- Source
- simplywall.st
The Real Question Buried Inside Merck Stock’s Premium Price
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jul 2026 21:50
- Source
- Trefis
Merck Reportedly Goes To Bat In Takeover Battle. But Genomics Stock Reverses.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jul 2026 20:12
- Source
- Investor's Business Daily
Merck Snags A First-Of-Its-Kind Approval, And Shares Jump
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 16 Jul 2026 20:07
- Source
- Investor's Business Daily
Merck (MRK) Stock Sees Modest Fair Value Lift As Analysts Raise Targets
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 16 Jul 2026 16:12
- Source
- Market source
Why Merck & Co. (MRK) Stock Is Up Today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 15:36
- Source
- Quiver Quantitative
Merck (MRK) Stock Looks Like A Bargain At This Price
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 13:09
- Source
- Market source
Merck (MRK) Stock Sinks As Market Gains: Here's Why
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 10 Jul 2026 07:00
- Source
- Market source
Merck (MRK) Stock Slides as Market Rises: Facts to Know Before You Trade
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 07:00
- Source
- Market source
Merck (MRK) Wins New KEYTRUDA Approvals As Tulisokibart Clears A Phase 3 Test
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jul 2026 07:00
- Source
- Market source
Stocks making the biggest moves premarket: AeroVironment, Strategy, Merck & more
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jun 2026 07:00
- Source
- CNBC
Merck (MRK) Stock Weighs Strong Rally Against Mixed Valuation Signals
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 26 Jun 2026 07:00
- Source
- Market source
Merck (MRK) Stock After 53% One-Year Gain Is DCF Signaling Further Upside Potential
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 12 Jun 2026 07:00
- Source
- Market source
Is Merck & Co. Stock Outperforming the S&P 500?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 May 2026 07:00
- Source
- Barchart.com
This Merck (MRK) Stock Bullish Diagonal Trade Targets a Price of $130 by June 18
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 15 Apr 2026 07:00
- Source
- Barchart.com
How Merck turned its wonder drug into a blockbuster — and priced out cancer patients worldwide - International Consortium of Investigative Journalists
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Apr 2026 07:00
- Source
- ICIJ
Merck & Co. Deepens Hematology Pipeline with $6.7 Billion Terns Acquisition
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 09 Apr 2026 07:00
- Source
- CHEManager
Merck nears $6 billion acquisition of Terns Pharma to boost cancer portfolio, FT reports
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 24 Mar 2026 07:00
- Source
- Reuters
Merck to create separate cancer division as Keytruda patent loss looms
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 23 Feb 2026 08:00
- Source
- Reuters
Merck Stock (MRK) Hitting Highs Into Earnings – Eyes On Breakout
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 03 Feb 2026 08:00
- Source
- AskTraders
Merck & Co. Stock Outlook: Is Wall Street Bullish or Bearish?
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 30 Jan 2026 08:00
- Source
- Barchart.com
Merck says new growth opportunities to drive revenue of $70 billion by mid-2030s
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 12 Jan 2026 08:00
- Source
- Reuters
Key deals this week: Merck, Glencore, CrowdStrike, Marvell Technology, Steel Dynamics and more
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jan 2026 08:00
- Source
- Seeking Alpha
Merck secures $700 million funding from Blackstone to develop cancer therapy
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Nov 2025 08:00
- Source
- Reuters
Merck Mounts $3 Billion Revamp as Keytruda Price Pressure Looms
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jul 2025 07:00
- Source
- Bloomberg.com
DELFI Diagnostics Announces Equity Investment from the Merck Global Health Innovation Fund to Accelerate DELFI's Cancer Screening AI Fragmentomics Platform
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jun 2024 07:00
- Source
- PR Newswire